Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II PTK787 study in metastatic cutaneous melanoma
ISRCTN00191981Phase 2Completed
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Jan 2006
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of vatalanib in cutaneous melanoma (CM), sponsored by Cambridge University Hospitals NHS Foundation Trust. Primary endpoint: Objective response rate. Started Jan 2006; status: completed.
02
Drugs
vatalanib
03
Conditions
cutaneous melanoma (CM)
Beyond the preview
Go deeper on ISRCTN00191981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN00191981.